Literature DB >> 29115136

Kinetic Control of Quorum Sensing in Pseudomonas aeruginosa by Multidrug Efflux Pumps.

David Wolloscheck1, Ganesh Krishnamoorthy1, Jennifer Nguyen1, Helen I Zgurskaya1.   

Abstract

Pseudomonas aeruginosa is an important human pathogen, the physiology and virulence of which are under the control of quorum sensing signals. These signals often have dual roles, functioning as toxins to some cells and as oxidative-stress protectors for their producer cells. Hence, their internal and external concentrations should be tightly controlled. In this study, we analyzed the interplay between the multidrug efflux transporters MexEF-OprN and MexG/HI-OpmD in quorum sensing of P. aeruginosa. We found that the two transporters have overlapping substrate specificities but different efficiencies. When overproduced, both MexEF-OprN and MexG/HI-OpmD provide clinical levels of resistance to diverse fluoroquinolones and protect P. aeruginosa against toxic phenazines. However, this similarity is enabled by synergistic interactions with the outer membrane. In hyperporinated cells, MexG/HI-OpmD is saturated by much lower concentrations of fluoroquinolones but is more efficient than MexEF-OprN in efflux of phenazines. Unlike MexEF-OprN, mutational inactivation of MexG/HI-OpmD reduces the levels of pyocyanin and makes P. aeruginosa cells hypersusceptible to phenazines. Our results further show that MexG binds pyocyanin, physically associates with MexHI, and represses the activity of the transporter, revealing a negative regulatory role of this protein. We conclude that differences in kinetic properties of transporters are critical to maintain proper intra- and extracellular concentrations of phenazines and other signaling molecules and that MexG/HI-OpmD controls the steady state in the synthesis and secretion of phenazines.

Entities:  

Keywords:  antibiotic resistance; efflux constant; hyperporination; outer membrane barrier; permeation; phenazines

Mesh:

Substances:

Year:  2017        PMID: 29115136      PMCID: PMC5807214          DOI: 10.1021/acsinfecdis.7b00160

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  40 in total

Review 1.  Sociomicrobiology: the connections between quorum sensing and biofilms.

Authors:  Matthew R Parsek; E P Greenberg
Journal:  Trends Microbiol       Date:  2005-01       Impact factor: 17.079

2.  Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa.

Authors:  T Köhler; C van Delden; L K Curty; M M Hamzehpour; J C Pechere
Journal:  J Bacteriol       Date:  2001-09       Impact factor: 3.490

3.  Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.

Authors:  Daniel J Wolter; Ellen Smith-Moland; Richard V Goering; Nancy D Hanson; Philip D Lister
Journal:  Diagn Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.803

4.  The putative response regulator BaeR stimulates multidrug resistance of Escherichia coli via a novel multidrug exporter system, MdtABC.

Authors:  Satoshi Nagakubo; Kunihiko Nishino; Takahiro Hirata; Akihito Yamaguchi
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

5.  Functional cloning and characterization of a multidrug efflux pump, mexHI-opmD, from a Pseudomonas aeruginosa mutant.

Authors:  Hiroshi Sekiya; Takehiko Mima; Yuji Morita; Teruo Kuroda; Tohru Mizushima; Tomofusa Tsuchiya
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

6.  Oxidative stress caused by pyocyanin impairs CFTR Cl(-) transport in human bronchial epithelial cells.

Authors:  Christian Schwarzer; Horst Fischer; Eun-Jin Kim; Katharine J Barber; Aaron D Mills; Mark J Kurth; Dieter C Gruenert; Jung H Suh; Terry E Machen; Beate Illek
Journal:  Free Radic Biol Med       Date:  2008-09-23       Impact factor: 7.376

7.  Pyocyanin alters redox homeostasis and carbon flux through central metabolic pathways in Pseudomonas aeruginosa PA14.

Authors:  Alexa Price-Whelan; Lars E P Dietrich; Dianne K Newman
Journal:  J Bacteriol       Date:  2007-05-25       Impact factor: 3.490

8.  The MexGHI-OpmD multidrug efflux pump controls growth, antibiotic susceptibility and virulence in Pseudomonas aeruginosa via 4-quinolone-dependent cell-to-cell communication.

Authors:  Séverine Aendekerk; Stephen P Diggle; Zhijun Song; Niels Høiby; Pierre Cornelis; Paul Williams; Miguel Cámara
Journal:  Microbiology (Reading)       Date:  2005-04       Impact factor: 2.777

9.  MexEF-OprN efflux pump exports the Pseudomonas quinolone signal (PQS) precursor HHQ (4-hydroxy-2-heptylquinoline).

Authors:  Martin G Lamarche; Eric Déziel
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

10.  Efflux-mediated fluoroquinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon.

Authors:  Yuji Morita; Junko Tomida; Yoshiaki Kawamura
Journal:  Front Microbiol       Date:  2015-01-21       Impact factor: 5.640

View more
  17 in total

1.  The Natural Product Elegaphenone Potentiates Antibiotic Effects against Pseudomonas aeruginosa.

Authors:  Weining Zhao; Ashley R Cross; Caillan Crowe-McAuliffe; Angela Weigert-Munoz; Erika E Csatary; Amy E Solinski; Joanna Krysiak; Joanna B Goldberg; Daniel N Wilson; Eva Medina; William M Wuest; Stephan A Sieber
Journal:  Angew Chem Int Ed Engl       Date:  2019-05-16       Impact factor: 15.336

2.  The putative bacterial oxygen sensor Pseudomonas prolyl hydroxylase (PPHD) suppresses antibiotic resistance and pathogenicity in Pseudomonas aeruginosa.

Authors:  Bettina Schaible; Bianca Crifo; Kirsten Schaffer; Cormac T Taylor
Journal:  J Biol Chem       Date:  2019-12-11       Impact factor: 5.157

Review 3.  From the soil to the clinic: the impact of microbial secondary metabolites on antibiotic tolerance and resistance.

Authors:  Elena K Perry; Lucas A Meirelles; Dianne K Newman
Journal:  Nat Rev Microbiol       Date:  2021-09-16       Impact factor: 60.633

4.  Molecular Properties That Define the Activities of Antibiotics in Escherichia coli and Pseudomonas aeruginosa.

Authors:  Connor J Cooper; Ganesh Krishnamoorthy; David Wolloscheck; John K Walker; Valentin V Rybenkov; Jerry M Parks; Helen I Zgurskaya
Journal:  ACS Infect Dis       Date:  2018-05-25       Impact factor: 5.084

Review 5.  Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier.

Authors:  Helen I Zgurskaya; Valentin V Rybenkov; Ganesh Krishnamoorthy; Inga V Leus
Journal:  Res Microbiol       Date:  2018-02-16       Impact factor: 3.992

Review 6.  Transporters Involved in the Biogenesis and Functionalization of the Mycobacterial Cell Envelope.

Authors:  Mary Jackson; Casey M Stevens; Lei Zhang; Helen I Zgurskaya; Michael Niederweis
Journal:  Chem Rev       Date:  2020-11-10       Impact factor: 60.622

7.  The Whole Is Bigger than the Sum of Its Parts: Drug Transport in the Context of Two Membranes with Active Efflux.

Authors:  Valentin V Rybenkov; Helen I Zgurskaya; Chhandosee Ganguly; Inga V Leus; Zhen Zhang; Mohammad Moniruzzaman
Journal:  Chem Rev       Date:  2021-02-17       Impact factor: 60.622

8.  Update on Multidrug Resistance Efflux Pumps in Acinetobacter spp.

Authors:  Vanessa Kornelsen; Ayush Kumar
Journal:  Antimicrob Agents Chemother       Date:  2021-06-17       Impact factor: 5.191

9.  Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.

Authors:  Helen I Zgurskaya; John K Walker; Jerry M Parks; Valentin V Rybenkov
Journal:  Acc Chem Res       Date:  2021-02-04       Impact factor: 22.384

10.  Loss of RND-Type Multidrug Efflux Pumps Triggers Iron Starvation and Lipid A Modifications in Pseudomonas aeruginosa.

Authors:  Justyna W Adamiak; Varsha Jhawar; Vincent Bonifay; Courtney E Chandler; Inga V Leus; Robert K Ernst; Herbert P Schweizer; Helen I Zgurskaya
Journal:  Antimicrob Agents Chemother       Date:  2021-07-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.